Chairman of the board of „Grindeks”, Janis Romanovskis: „It is still too early to talk about new cooperation partners – interests have to be mutually evaluated, provisions have to be precised, and only then can a decision be adopted. The pharmaceutical business is complicated, time-consuming and strictly regulated – sometimes several years can pass from negotiations till real cooperation.”

 

At the exhibition “Grindeks” has been presented with wide range of service offers in the research, development, manufacture, registration and sales domains. The participation in this, as well as other exhibitions, is significant, not only in order to meet existing cooperation partners, but also to present one’s own company and products on a global basis, to create new business contacts, as well as to find out about the development tendencies, latest inventions and technologies. In general, approximately 90 meetings have been organized at the “Grindeks” booth” during the exhibition.

 

Chairman of the board of „Grindeks”, Janis Romanovskis: „During previous year, when we have taken part in the „CPhI” exhibition with our booth, it already has become sure for us, that we can compete at the global pharmaceutical market as a reliable, stable and qualitative partner. In order to minimize the influence of negative global economic processes, “Grindeks” concentrates more and more on the diversification of its business; the participation in the exhibition is a purposeful marketing project, and in the future we will be able to speak of specific results.”

 

This year the “CPhI Worldwide 2009” exhibition has been extensively visited - approximately 1000 companies from 125 countries of the world have taken part therein. In comparison with the previous year, less activity has been observed at the exhibition; however, with each year, the preparation to the exhibition takes place on more and more professional level, both on the part of organizers and participants. Well before the exhibition, the participants are offered wide opportunities on advertising, both in internet and in specialized catalogues, which allows to evaluate potential cooperation partners in advance, to invite them to a meeting at the exhibition and to go there already with a specific aim.

 

The participation of “Grindeks” at the exhibition has been co-financed by the European Regional Development Fund.

 

“Grindeks” is the leading pharmaceutical company in the Baltic States. The main directions of its operation are research, development, manufacturing and sales of original products, as well as generics and active pharmaceutical ingredients. “Grindeks” specializes in the heart and cardiovascular, psychotropic and anti-cancer therapeutic groups of medications.

 

„Grindeks” concern consists of four subsidiary companies in Latvia, Estonia and Russia; as well as representatives and representative offices in 14 countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, as well as Japan and USA. The shares of JSC „Grindeks” are listed in the Official List of „NASDAQ OMX Riga”.

                                         

Laila Kļaviņa
Head of the Communications Department
JSC „Grindeks”
E-mail: laila.klavina@grindeks.lv
Phones: +371 67083370, +371 29256012